Unlock the full potential of human primary cell culture: Discover our new cell culture brochure

Find out how our extensive portfolio of cell culture media for a wide variety of human primary cells and cancer cells can help you achieve more accurate, reliable, and reproducible results. Our new human cell culture brochure is here to help.

Explore our wide range of human primary cells, mesenchymal stem cells, and blood and immune cell types.

Our new brochure is designed to help you get the most out of your human cell culture experiments. With our comprehensive portfolio of human cell culture media, you can optimize cell growth, differentiation, and function for a wide range of applications. Whether you are working with mesenchymal stem cells, blood and immune cells, or other types of primary cells or cancer cells, our high-quality products and expert technical support can help you achieve your research goals.

In addition to our extensive range of human cell culture products, our brochure also highlights our services for cell and gene therapy development. From cell sourcing and characterization to process development and GMP manufacturing, we offer end-to-end solutions to help you bring your cell therapy to market.

Download our human cell culture brochure

Download our brochure today and unlock the full potential of your human cell culture.

Get the brochure

Choose your Region

Please choose your region for an optimized website experience. So we can provide you with the most useful information for your country.

  1. North America
    1. Canada
    2. United States
  2. Europe
    1. Austria
    2. Belgium
    3. Bulgaria
    4. Croatia
    5. Czech Republic
    6. Denmark
    7. Finland
    8. France
    9. Germany
    10. Greece
    11. Hungary
    12. Ireland
    13. Italy
    14. Luxembourg
    15. Monaco
    16. Netherlands
    17. Norway
    18. Poland
    19. Portugal
    20. Romania
    21. Slovakia
    22. Slovenia
    23. Spain
    24. Sweden
    25. Switzerland
    26. United Kingdom
  3. Asia
    1. India
    2. Israel
    3. Japan
    4. Malaysia
    5. Singapore
    6. South Korea
    7. Taiwan
    8. Thailand
Scroll to top